2^nd International Conference Neurooncology and Neurosurgery April 24, 25 2017 Dubai, UAE.

Bruno Giometto, MD, is the director of Dept. of Neurology in Padova and was coordinator of the PNS Euronetwork. He has published more than 80 papers in peer-reviewed journals. He is Vice-President of the Italian Neurological Society.

Neuro Oncology, Neurology

Carmen Balaña is the director of Dept. of Neurology &was coordinator of the PNS Euronetwork. He has published more than 80 papers in peer-reviewed journals.

neurology and neurooncology

Nancy Ratner, PhD, is interested in understanding mechanisms of peripheral nerve tumor (neurofibroma) formation in neurofibromatosis type 1 (NF1), a common inherited disorder in which children are predisposed to cancer of the nervous system, to learning problems, bone disorders, and other cancers. She identified EGFR and MEK as potential therapeutic targets in NF1 peripheral nerve tumorigenesis, and has developed cell culture and mouse models of NF1 nerve tumorigenesis. Her laboratory has also used analysis of gene expression to identify critical genes in neurofibroma and their malignant derivatives, MPNST.Dr. Ratner received her bachelor's from Brown University, her doctorate from Indiana University, and was a postdoctoral fellow at Washington University in St. Louis. She was a member of the faculty at the University of Cincinnati from 1987 to 2004.

Dr. Ratner is currently a professor in the Department of Pediatrics, Cincinnati Children’s Hospital Medical Center, University of Cincinnati, and the program leader for Cancer Biology and Neural Tumors Program in the Cancer and Blood Diseases Institute where she holds the Beatrice C. Lampkin Endowed chair in cancer biology and serves as PI of the NINDS P50 “Cincinnati Center in NF Research.”Dr. Ratner is an active member of the International Consortium on the Molecular Biology of NF1, NF2, and Schwannomatosis and was a member of the advisory board for the National Neurofibromatosis Foundation (now Children’s Tumor Foundation) from 1989 to 2007. She chaired the Department of Defense Neurofibromatosis Research Program Integration Panel in 2008, and currently serves as a member of the James McDonnell Brain Tumor Research Advisory Board. She received the von Recklinghausen Award from the Children’s Tumor Foundation in 2010 and the Jacob K. Javits Neuroscience Investigator Award (NIH-NINDS MERIT Award) in 2014

Guido Cavaletti, MD, is a certified neurologist since 1990. He is the Head of the Experimental Neurology Unit at the University of Milano-Bicocca and has a long-lasting experience in the preclinical and clinical assessment of CIPN. He has published more than 200 full papers in peer-reviewed journals, he is is consulted by the FDA, NIH and EMA and has been serving as associate editor of the Journal of the Peripheral Nervous System and as editorial board member of Experimental neurology and Current medicinal Chemistry.

neurology

Dr. Aizenberg is an Associate Professor of Neurosurgery at the University of Nebraska Medical Center. She is Board Certified by the American Board of Neurological Surgery. Dr. Aizenberg has completed fellowship training in Neurosurgical Oncology at The University of Texas M. D. Anderson Cancer Center and has a special interest in primary and metastatic tumors of the brain and spine.

Neurosurgery, Neurooncology

Associate Professor of Neurosurgery at the University of Nebraska Medical Center. She is Board Certified by the American Board of Ammirati Mario is an expert in Neurological Surgery.He has completed fellowship training in Neurosurgical Oncology at The The Ohio State University and has a special interest in primary and metastatic tumors of the brain and spine.

Primary and metastatic tumors of the brain and spine.

Associate Professor of Neurosurgery at the University of Nebraska Medical Center. She is Board Certified by the American Board of Ammirati Mario is an expert in Neurological Surgery.He has completed fellowship training in Neurosurgical Oncology at The The Ohio State University and has a special interest in primary and metastatic tumors of the brain and spine.

Spine and Cancer